Equitable Trust Co. Purchases Shares of 37,298 iShares Biotechnology ETF $IBB

Equitable Trust Co. purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 1st quarter, HoldingsChannel reports. The fund purchased 37,298 shares of the financial services provider’s stock, valued at approximately $6,298,000.

A number of other hedge funds also recently made changes to their positions in IBB. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the 2nd quarter valued at approximately $25,000. Basepoint Wealth LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $26,000. Cary Street Partners Financial LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $29,000. Copia Wealth Management bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at $34,000. Finally, Caitlin John LLC bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at $34,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 0.5%

IBB opened at $197.34 on Friday. iShares Biotechnology ETF has a twelve month low of $128.84 and a twelve month high of $199.05. The company has a fifty day moving average of $175.36 and a 200-day moving average of $172.67.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were given a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.0%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.